---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-101167"
form_type: "8-K"
ticker: "LCTX"
cik: "0000876343"
company_name: "Lineage Cell Therapeutics, Inc."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T15:21:09.274749+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Lineage Cell Therapeutics files prospectus supplement for up to $60M ATM offering

## Summary
- Offers up to $60,000,000 of common shares in at-the-market offering through B. Riley Securities.
- Prior sales under the same shelf registration total $22,583,664 in aggregate gross proceeds.
- Prospectus supplement dated March 11, 2026 supplements shelf registration effective May 14, 2024.

## SEC filing metadata
- accession: 0001193125-26-101167
- form_type: 8-K
- ticker: LCTX
- cik: 0000876343
- company_name: Lineage Cell Therapeutics, Inc.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/0001193125-26-101167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/876343/000119312526101167/lctx-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-101167
- JSON: https://secwatch.observer/filing/0001193125-26-101167.json
- Plain text: https://secwatch.observer/filing/0001193125-26-101167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.